About Velsera

Medicine moves too slow. At Velsera, we are changing that.

Velsera was formed in 2023 through the shared vision of Seven Bridges and Pierian, with a mission to accelerate the discovery, development, and delivery of life-changing insights.

Velsera provides software and professional services for:

• AI-powered multimodal data harmonization and analytics for drug discovery and development
• IVD development, validation, and regulatory approval
• Clinical NGS interpretation, reporting, and adoption

With our headquarters in Boston, MA, we are growing and expanding our teams located in different countries!

About the role 

Velsera builds and operates precision medicine software across the Seven Bridges Platform (SBP), Clinical Genomics Workspace (CGW), and FastFinder. Our teams support genomic researchers, clinical labs, and pharma customers—often in ...